Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 11425946.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Deficient orexin signaling has been shown to cause narcolepsy-like conditions in animals. In human narcolepsy, CSF levels of orexin A (hypocretin-1) were reported to be low in most cases. The authors measured CSF and plasma orexin A levels in patients with narcolepsy and in controls. Confirming earlier studies, they found CSF orexin A levels to be extremely low in patients with narcolepsy. However, plasma orexin A levels did not differ from those observed in controls. These results suggest that orexin deficiency in patients with narcolepsy is a phenomena restricted to the CNS.
Medical subject headings
- Carrier Proteins
- Intracellular Signaling Peptides and Proteins
- Narcolepsy
- Neuropeptides